LifeStance Health Group Inc (NASDAQ:LFST) stock Market Value Reached at $2.10 billion: What Happened? – BOVNews (2024)

• Lloyd Martinez
• July 20, 2024
• Companies

Barclays raised the price target for the LifeStance Health Group Inc (NASDAQ:LFST) stock to “an Underweight”. The rating was released on January 03, 2024, according to finviz. We previously noted in another research note published on May 15, 2023 by TD Cowen that downgraded the stock from an Outperform to a Market perform with a price target of $9 for LFST stock. The research report from Morgan Stanley has upgraded the stock from Equal-Weight to Overweight, with a price target set at $8. The stock was resumed by Jefferies, who disclosed in a research note on November 07, 2022, to Buy and set the price objective to $7.25. In their research brief published March 17, 2022, UBS analysts downgraded the LifeStance Health Group Inc stock from Buy to Neutral with a price target of $10.

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated 3.19% within the last five trades and 3.97% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -18.64% in the last 6 months and -3.68% was subtracted to its value over the previous 3 months. LFST stock is trading at a margin of 5.76%, -4.90% and -13.08% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

Sponsored

As of the close of trading, LFST deals in the Healthcare domain. The stock is trading -42.11 percent below its 52-week high and 18.53 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -35.6. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does LifeStance Health Group Inc’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at -15.43 percent and the profit margin is -15.69 percent, and the company has reported a gross margin of 22.05 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $2.10 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.91 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.47, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 70.92 percent of LifeStance Health Group Inc shares are owned by insiders, and 26.36 percent are held by financial institutions. Qureshi Danish J., the at LifeStance Health Group Inc (LFST) has sold 150,000 shares of firm on Jun 14 ’24 at a price of $5.21 against the total amount of $0.78 million. In another inside trade, Pardo Ryan, of LifeStance Health Group Inc (NASDAQ:LFST) sold 61,508 shares of the firm on Jun 12 ’24 for a total worth of $0.33 million at a price of $5.40. An inside trade which took place on Jun 11 ’24, Chief Development Officer of LifeStance Health Group Inc Mullins Kevin Michael sold 85,093 shares of firm against total price of $0.47 million at the cost of $5.53 per share.

• TagsLFST, LFST stock, LifeStance Health Group Inc., NASDAQ:LFST

BOVNews.com was originated in 2018 as a Company. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance.

• Home
• Our Company
• Contact Us
• Disclaimer
• Privacy Policy

• Industry
• Companies
• Finance
• Market

No thanks, I'm not interested.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.